Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. M. Lee, H. Le, B. T. Lee, N. D. Wong (Irvine, United States Of America). Assessment of pulmonary function stratifies global coronary heart disease risk. Eur Respir J 2009; 34: Suppl. 53, 1003

Member's Comments

No comment yet.

Related content which might interest you: Assessment of cardiovascular comorbidity Source: Eur Respir Mon 2013; 59: 28-49 Year: 2013 Heart failure and coronary artery disease in lung disease Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018 Evaluation of pulmonary functions in valvular heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002 Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 COPD phenotypes not linked to increased risk of coronary heart disease Source: International Congress 2019 – Comorbidities galore in respiratory patients Year: 2019 Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006 Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017 Year: 2018 Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients Source: ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020 Year: 2020 Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Impact of COPD in patients with coronary heart disease submitted to coronary heart bypass graft Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015 Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD) Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Pulmonary hypertension associated with left heart disease Source: Eur Respir Mon 2012; 57: 119-137 Year: 2012